631 results
SD
EX-1.01
TEVA
Teva- Pharmaceutical Industries Ltd.
30 May 24
Conflict minerals disclosure
4:25pm
/CINQAERO®, DuoResp® Spiromax® and AirDuo® RespiClick®.
2. Supply Chain
We source a large portion of our APIs from our own manufacturing facilities … . Reasonable Country of Origin Inquiry
5.1. Conflict Minerals Reporting Template
We conducted an in-depth review of our supply chain, and surveyed those
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
15 May 24
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
8:30am
-to-end manufacturing, supply chain, procurement, and process development. Prior to Merck, he led Specialty Care Manufacturing, Engineering … Operations, and my colleagues across the Company, to deliver on our inspiring purpose.”
Matthew Shields Bio
Mr. Shields is a manufacturing and supply chain leader
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
15 May 24
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
8:30am
, is a manufacturing and supply chain leader with more than 25 years of experience in the biopharmaceuticals and animal health industries. Prior to joining Teva
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
to attract, hire, integrate and retain highly skilled personnel; interruptions in our supply chain or problems with internal or third party manufacturing
8-K
EX-99.1
ao2saepwkx
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
3w8w4y3zumv fzt
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
dh29r
2 Aug 23
Results of Operations and Financial Condition
7:00am
SD
EX-1.01
eanoi mq7awag8
24 May 23
Conflict minerals disclosure
12:00am
8-K
EX-99.1
swqc4j
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
kvq3cdp29odwssscf
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
1vnm3ic7xs
26 Jul 22
Key financial highlights and outlook
4:56pm